Page 214 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 214
Viral Hepatitis: Hepatitis B & D - Experimental (Cont.)
P0549 THE USEFULNESS OF CLIF-SOFA SCORE FOR
PREDICTING SHORT-TIME MORTALITY OF PATIENTS
WITH HBV-RELATED ACUTE-ON-CHRONIC LIVER
FAILURE IN CHINA
Chen Li, Zhihong Wan, Shaoli You, Hongling Liu, Shaojie Xin*, China
P0550 THE IMPACTS OF BASELINE CLINICAL CHARACTERISTICS
AND HEPATITIS B VIRUS MUTATIONS ON CURATIVE
EFFECTS OF CHRONIC HEPATITIS B TREATED WITH
NOVAFERON
Wu Daxian, Tan Deming*, China
P0551 THE CRISPR/CAS9 SYSTEM BEING AS A CUTTER FOR
COVALENTLY CLOSED CIRCULAR DNA OF HEPATITIS B
VIRUS
Xiao-Ben Pan*, Xing-Liang Zhao, Lai Wei, China
P0552 VITAMIN D HAS NO DIRECT EFFECT ON HEPATITIS B
VIRUS REPLICATION AND TRANSCRIPTION
ePOSTERS Neta Gotlieb, Maya Sultan, Michal Safran, Ziv Ben-Ari*, Israel
TOP 10% POLO-LIKE-KINASE 1, A POSITIVE EFFECTOR IN
YI P0553 HEPATITIS B VIRUS REPLICATION: THERAPEUTIC
IMPLICATIONS
Ahmed Diab*, Adrien Foca, Pascal Jalaguier, Lia N’guyen,
Nathalie Isorce, Fabien Zoulim, Ourania Andrisani, David Durantel,
Egypt
TOP 10% HEPATITIS E VIRUS INFECTION INDUCES AN INNATE
YI P0554 IMMUNE RESPONSE IN HUMAN CHIMERIC MICE
Lena Allweiss*, Sofia Gass, Tassilo Volz, Katja Giersch, Janine Kah,
Ansgar W. Lohse, Joerg Petersen, Susanne Polywka, Sven Pischke,
Maura Dandri, Marc Lütgehetmann, Germany
YI P0555 INSERTIONS AND/OR DELETIONS IN THE MAIN
REGULATORY REGION OF HEPATITIS B VIRUS SUGGEST
MULTICODING OF THE X PROTEIN
Andrea Caballero*, Josep Gregori, Maria Buti, David Tabernero,
Josep Quer, Maria Blasi, Francisco Rodriguez-Algarra, Rosario Casillas,
Carolina González, Irene Belmonte, Leonardo Nieto, Xose Costa,
Rafael Esteban, María Homs, Francisco Rodriguez-Frías, Spain
214 The International Liver Congress™ 2015 • ILC Programme
P0549 THE USEFULNESS OF CLIF-SOFA SCORE FOR
PREDICTING SHORT-TIME MORTALITY OF PATIENTS
WITH HBV-RELATED ACUTE-ON-CHRONIC LIVER
FAILURE IN CHINA
Chen Li, Zhihong Wan, Shaoli You, Hongling Liu, Shaojie Xin*, China
P0550 THE IMPACTS OF BASELINE CLINICAL CHARACTERISTICS
AND HEPATITIS B VIRUS MUTATIONS ON CURATIVE
EFFECTS OF CHRONIC HEPATITIS B TREATED WITH
NOVAFERON
Wu Daxian, Tan Deming*, China
P0551 THE CRISPR/CAS9 SYSTEM BEING AS A CUTTER FOR
COVALENTLY CLOSED CIRCULAR DNA OF HEPATITIS B
VIRUS
Xiao-Ben Pan*, Xing-Liang Zhao, Lai Wei, China
P0552 VITAMIN D HAS NO DIRECT EFFECT ON HEPATITIS B
VIRUS REPLICATION AND TRANSCRIPTION
ePOSTERS Neta Gotlieb, Maya Sultan, Michal Safran, Ziv Ben-Ari*, Israel
TOP 10% POLO-LIKE-KINASE 1, A POSITIVE EFFECTOR IN
YI P0553 HEPATITIS B VIRUS REPLICATION: THERAPEUTIC
IMPLICATIONS
Ahmed Diab*, Adrien Foca, Pascal Jalaguier, Lia N’guyen,
Nathalie Isorce, Fabien Zoulim, Ourania Andrisani, David Durantel,
Egypt
TOP 10% HEPATITIS E VIRUS INFECTION INDUCES AN INNATE
YI P0554 IMMUNE RESPONSE IN HUMAN CHIMERIC MICE
Lena Allweiss*, Sofia Gass, Tassilo Volz, Katja Giersch, Janine Kah,
Ansgar W. Lohse, Joerg Petersen, Susanne Polywka, Sven Pischke,
Maura Dandri, Marc Lütgehetmann, Germany
YI P0555 INSERTIONS AND/OR DELETIONS IN THE MAIN
REGULATORY REGION OF HEPATITIS B VIRUS SUGGEST
MULTICODING OF THE X PROTEIN
Andrea Caballero*, Josep Gregori, Maria Buti, David Tabernero,
Josep Quer, Maria Blasi, Francisco Rodriguez-Algarra, Rosario Casillas,
Carolina González, Irene Belmonte, Leonardo Nieto, Xose Costa,
Rafael Esteban, María Homs, Francisco Rodriguez-Frías, Spain
214 The International Liver Congress™ 2015 • ILC Programme
